Skip to Main Content

Author Details

David W Stroman
University of Washington School of Medicine, and NovaBay Pharmaceuticals
1977
46
18
PMIDPaper TitleJournal TitlePublished Year
34740631Molecular and Clinical Characterization of Human Adenovirus E4-Associated Conjunctivitis.Am J Ophthalmol2022
36531578Machine Learning Prediction of Adenovirus D8 Conjunctivitis Complications from Viral Whole-Genome Sequence.Ophthalmol Sci2022
29602567Determinants of Outcomes of Adenoviral Keratoconjunctivitis.Ophthalmology2018
28458509Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin.Clin Ophthalmol2017
27279412Evaluating the role of embolization and carotid artery sacrifice and reconstruction in the management of carotid body tumors.Laryngoscope2016
26038392Carotid Artery Sacrifice and Reconstruction in the Setting of Advanced Head and Neck Cancer.Otolaryngol Head Neck Surg2015
25136406Management of carotid artery trauma.Craniomaxillofac Trauma Reconstr2014
23341010Broad-spectrum virucidal activity of (NVC-422) N,N-dichloro-2,2-dimethyltaurine against viral ocular pathogens in vitro.Invest Ophthalmol Vis Sci2013
22074357Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat.J Pediatr Ophthalmol Strabismus2012
22562783Safety and efficacy of moxifloxacin-dexamethasone eyedrops as treatment for bacterial ocular infection associated with bacterial blepharitis.Adv Ther2012
20875711Traumatic internal carotid artery injury treated with overlapping bare metal stents under intravascular ultrasound guidance.J Vasc Surg2011
21604820The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.Clin Drug Investig2011
21681652Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.Adv Ther2011
21060106Metallo-beta-lactamase production by Pseudomonas otitidis: a species-related trait.Antimicrob Agents Chemother2011
20174904Comparison of fluoroquinolone kinetics of kill in susceptible and resistant gram-positive conjunctival pathogens.Adv Ther2010
20463315A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.Invest Ophthalmol Vis Sci2010
19192973Differences in bacteriologic treatment failures in acute otitis externa between ciprofloxacin/dexamethasone and neomycin/polymyxin B/hydrocortisone: results of a combined analysis.Curr Med Res Opin2009
20028267Re: Association between moxifloxacin ophthalmic solution and fungal infection in patients with corneal ulcers and microbial keratitis.J Ocul Pharmacol Ther2009
19116600Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.Pediatr Infect Dis J2009
19293445DNA sequencing by Microseq kit targeting 16S rRNA gene for species level identification of mycobacteria.Indian J Med Res2009
18369536The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.Adv Ther2008
19043945A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.J Pediatr Ophthalmol Strabismus2008
18309465Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension.Adv Ther2008
17606592Choosing the best practice: evidence to support fluoroquinolone drops for acute otitis media through tympanostomy tubes.Pediatrics2007
18029337Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: clinical implications and a review of kinetics of kill studies.Adv Ther2007
16585681Pseudomonas otitidis sp. nov., isolated from patients with otic infections.Int J Syst Evol Microbiol2006
16966141Virulence factor profiles and antimicrobial susceptibilities of ocular bacillus isolates.Curr Eye Res2006
16880248Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.Pediatrics2006
16491721Controlling contagious bacterial conjunctivitis.J Pediatr Ophthalmol Strabismus2006
16257308In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone.Surv Ophthalmol2005
28221457A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.Eur J Ophthalmol2005
16167284A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.Eur J Ophthalmol2005
16213934Microbiology of acute otitis media with tympanostomy tubes.Otolaryngol Head Neck Surg2005
14702493Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes.Pediatrics2004
15324520Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa.Curr Med Res Opin2004
14660913Topical ciprofloxacin/dexamethasone is superior to ciprofloxacin alone in pediatric patients with acute otitis media and otorrhea through tympanostomy tubes.Laryngoscope2003
12974053Update on methods of assessing microbiologic success or failure in patients with otic disease.Ear Nose Throat J2003
12410042Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis.Cornea2002
12169893Microbiology of acute otitis externa.Laryngoscope2002
11685070Effectiveness of ciprofloxacin and ofloxacin in a prophylaxis model of Staphylococcus keratitis.Cornea2001
11801996Microbiology of normal external auditory canal.Laryngoscope2001
11821987The effectiveness of tobramycin and Ocuflox in a prophylaxis model of Staphylococcus keratitis.Curr Eye Res2001
10817723Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998).Antimicrob Agents Chemother2000
10550795Serratia marcescens keratitis: strain-specific corneal pathogenesis in rabbits.Curr Eye Res1999
6630064U-56,407, a new antibiotic related to asukamycin: isolation and characterization.J Antibiot (Tokyo)1983
404965Microbial formation of 4-thiouracil.Antimicrob Agents Chemother1977
  • 1 - 46 of 46

Recommended Authors

New York University School of Medicine
Career Start Year 2010
Number of shared co-authors 0
The Cornea Institute, L V Prasad Eye Institute
Career Start Year 2010
Number of shared co-authors 4
University of California, Davis Center for Valley Fever
Career Start Year 2005
Number of shared co-authors 0
Institute for Infectious Diseases, University of Bern
Career Start Year 2004
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 0
Aravind Eye Hospital and Postgraduate Institute of Ophthalmology
Career Start Year 2002
Number of shared co-authors 4
F.I. Proctor Foundation, University of California san francisco
Career Start Year 2001
Number of shared co-authors 7
Wayne State University
Career Start Year 2000
Number of shared co-authors 0
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 0
Waterbury Hospital
Career Start Year 1998
Number of shared co-authors 0
Shantilal Shanghvi Cornea Institute, LV Prasad Eye Institute
Career Start Year 1997
Number of shared co-authors 4
F.I. Proctor Foundation, University of California san francisco
Career Start Year 1997
Number of shared co-authors 5
Aravind Eye Hospital and Postgraduate Institute of Ophthalmology
Career Start Year 1995
Number of shared co-authors 4
University of Illinois at Chicago
Career Start Year 1995
Number of shared co-authors 4
F.I. Proctor Foundation, University of California san francisco
Career Start Year 1992
Number of shared co-authors 4
University of Pittsburgh Medical Center
Career Start Year 1991
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 1990
Number of shared co-authors 4
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 0
Transilvania University
Career Start Year 1988
Number of shared co-authors 0
Francis I Proctor Foundation, University of California san francisco
Career Start Year 1988
Number of shared co-authors 4
Johns Hopkins Wilmer Eye Institute (T.M.L., Johns Hopkins University
Career Start Year 1987
Number of shared co-authors 4
L V Prasad Eye Institute
Career Start Year 1987
Number of shared co-authors 4
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 4
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Career Start Year 1986
Number of shared co-authors 0
Aravind Eye Hospital
Career Start Year 1984
Number of shared co-authors 4
Primary Children's Hospital
Career Start Year 1984
Number of shared co-authors 0
Bascom Palmer Eye Institute, University of Miami
Career Start Year 1983
Number of shared co-authors 4
University of Toronto, and University Health Network, Toronto General Hospital
Career Start Year 1982
Number of shared co-authors 0
Moorfields Eye Hospital NHS Foundation Trust, The UCL Institute of Ophthalmology
Career Start Year 1979
Number of shared co-authors 4
Massachusetts General Hospital
Career Start Year 1962
Number of shared co-authors 0

Collaborators

NovaBay Pharmaceuticals, Inc.
Co-authored papers 3
University of Washington School of Medicine, and NovaBay Pharmaceuticals
Co-authored papers 3
University of Washington School of Medicine
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Harvard University, Moorfields Eye Hospital NHS Foundation Trust, St. John's Mercy Hospital, University of British Columbia, University of Washington, Washington University in Saint Louis
Co-authored papers 2
University of Washington
Co-authored papers 2
University of Washington School of Medicine
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Washington
Co-authored papers 1
University of Washington School of Medicine
Co-authored papers 1
Co-authored papers 1
University of Washington School of Medicine
Co-authored papers 1
Federal University of Sao Paulo
Co-authored papers 1
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Eurofins Viracor Clinical Diagnostics
Co-authored papers 1
University of Washington
Co-authored papers 1
Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School
Co-authored papers 1